Article information
Se revisan las indicaciones, técnicas y agentes utilizados en la producción de pleurodesis.
El talco y el clorhidrato de tetraciclina obtienen los mejores resultados con el menor índice de morbilidad. Se propone como método de elección el talcage por toracoscopia o el clorhidrato de tetraciclina introducido por drenaje torácico.
The indications, techniques and agents used for pleurodesis are reviewed.
Talcum powder and tetracycline chlorhydrate will furnish the most satisfactory results with the lowest morbidity.
The two recommended methods are thorascopy with talcum powder or tetracycline chlorhydrate introduced through thoracic drainage.
Full text is only aviable in PDF
Bibliografia
[1.]
L. Spengler.
Zur Chirurgie des Pneumothorax: Mitteilung über 10 eigene Falle von geheilten tuberkulosen Pneumothorax, verbunden in 6 Fallen mit gleichzeitiger Heilung der Lungentuberkulose.
Beitr Z Klin Chir, 49 (1906), pp. 68-89
[2.]
N. Bethune.
Pleural poudrage —a new technique for the deliberate production of pleural adhesions as a preliminary to lobectomy.
J Thorac Surg, 4 (1935), pp. 251-261
[3.]
J.H. Müller.
Über die Verwendung von künstlichen radioaktiven Isotopen zur Erzielung von localsierten biologischen Strahlenwirkungen.
Experientia, 1 (1945), pp. 199-200
[4.]
D.A. Karnofsky, W.H. Abelmann, L.F. Craver.
The use of the nitrogen mustards in the palliative treatment of carcinoma: with particular reference to bronchogenic carcinoma.
Cancer, 1 (1948), pp. 634-656
[5.]
J. Albertelli, H. Monaco, T. O’Connor.
Mostaza nitrogenada en cavidades serosas para el tratamiento de tumores malignos avanzados.
Prensa Med Argent, 41 (1954), pp. 201-205
[6.]
J.C. Bateman, B. Moulton, N.J. Larsen.
Control of neoplastic effusion by phosphoramide chemotherapy.
AMA Arch Intern Med, 95 (1955), pp. 713-719
[7.]
A. Gelhorn, J. Zaidenweber, J. Ultman, E. Hirschberg.
The use of Atabrine (Quinacrine) in the control of recurrent neoplastic effusions.
Dis Chest, 39 (1961), pp. 165-176
[8.]
R.M. Rubinson, H. Bolooki.
Intrapleural tetracycline for control of malignant pleural effusion: a preliminary report.
South Med J, 65 (1972), pp. 847-849
[9.]
D.D. Storey, D.E. Dines, D.T. Coles.
Derrame pleural: un problema diagnóstico.
JAMA (Ed Esp), 2 (1976), pp. 999
[10.]
Hirsch A, Ruffie P, Nebut M. Pleural effusion: laboratory test in 300 cases.
[11.]
A. Cantó, E. Blasco, M. Casillas, A.G. Zarza, J. Padilla, J. Pastor, V. Tarazona, F. París.
Thoracoscopy in the diagnosis of pleural effusions.
Throax, 32 (1977), pp. 550-554
[12.]
G.W. Starkey.
Recurrent malignant pleural effusions.
N Engl J Med, 270 (1964), pp. 436-438
[13.]
C.B. Anderson, G.W. Philpott, T.B. Ferguson.
The treatment of malignant pleural effusions.
Cancer, 33 (1974), pp. 916-922
[14.]
B. Chermow, S.A. Sahn.
Afección carcinomatosa de la pleura: estudio de 96 pacientes.
Am J Med (Ed Esp), 6 (1977), pp. 366-373
[15.]
A. Cantó, E. Blasco, M. Casillas, A. García-Zarza, J. Pastor, V. Tarazona, F. París.
Toracoscopia diagnóstica.
Arch Bronconeumol, 12 (1976), pp. 24-27
[16.]
A. Sueiro, J. Villamor, A.E. Delgado, J. Serrano, J. Ortiz.
La toracoscopia y biopsia pleural en los derrames pleurales no supurados.
Arch Bronconeumol, 13 (1977), pp. 7-11
[17.]
A. Cantó, J. Rivas, J. Saumench, R. Morera, J. Moya.
Points to consider when choosing a biopsy method in cases of pleurisy of unknown origin.
Chest, 84 (1983), pp. 176-179
[18.]
L. Taylor.
A catheter technique for intra-pleural administration of alkylating agents: a report of ten cases.
Am J Med Sci, 244 (1962), pp. 706-716
[19.]
A.A. Frachia, W.H. Knapper, J.T. Carey, J. Farrow.
Intrapleural chemotherapy for effusion from metastatic breast carcinoma.
Cancer, 26 (1970), pp. 626-629
[20.]
S. Curró.
Local chemotherapy of neoplastic pleural and peritoneal effusion.
Panminerva Med, 16 (1974), pp. 91-92
[21.]
J.E. Ultman.
Diagnostic and treatment of neoplastic effusion.
Cancer, 12 (1962), pp. 42-50
[22.]
C.J. Lambert, H.H. Shah, H.C. Urschel.
The treatment of malignant pleural effusions by closed trocar tube drainage.
Ann Thorac Surg, 3 (1967), pp. 1-5
[24.]
M.R. Dollinger.
Management of recurrent malignant effusions.
Cancer, 22 (1972), pp. 138-147
[25.]
R. Titscher, O. Kokron, K. Letnansky.
Zur lokalen Therapie maligner Pleurarergüsse.
Wien Klin Woch, 85 (1973), pp. 338-340
[26.]
J. Alan.
Pleural effusion in malignant form.
Ann lntern Med, 88 (1978), pp. 532-537
[27.]
E.H. Austin, M.W. Flye.
The treatment of recurrent malignant pleural effusions.
Ann Thorac Surg, 28 (1979), pp. 190-203
[28.]
E.M. Braun, F.I.A. Schlang.
Large-tube drainage of malignant pleural effusion.
NY State J Med, 75 (1975), pp. 1550-1551
[29.]
R. Izbicki, B.T. Weyhing, L. Baker, E.M. Caoili, V.K. Vaitkevicius.
Pleural effusion in cancer patients — A prospective randomized study of pleural drainage with the addition of radioactive phosphorous to the pleural space vs pleural drainage alone.
Cancer, 36 (1975), pp. 1511-1518
[30.]
S.J. Strober, E. Klotz, A. Kuperman.
Malignant pleural disease — A radiotherapeutic approach to the problem.
JAMA, 226 (1973), pp. 296-299
[31.]
J.K. Weick, J.M. Kiely, E.G. Harrison.
Pleural effusion in lymphoma.
Cancer, 31 (1973), pp. 848-853
[32.]
R. Jensik, J.E. Cagle, F. Milloy.
Pleurectomy in the treatment of pleural effusion due to metastatic malignancy.
J Thorac Cardiovasc Surg, 46 (1963), pp. 322-330
[33.]
N. Martini, M.S. Bains, E.J. Beattie.
Indications for pleurectomy in malignant effusion.
Cancer, 35 (1975), pp. 734-738
[34.]
J.A. Di Paolo, H. Franklin, J. Gallagher.
The use of human tumor effusions in primary culture for testing chemotherapeutic compounds.
Cancer, 17 (1964), pp. 391-394
[35.]
J.B.D. Mark, I.S. Goldberg, A.C. Montague.
Intrapleural mechlorethamine hydrochloride therapy for malignant pleural effusion.
JAMA, 187 (1964), pp. 858-860
[36.]
F.G. Pearson, D.C. McGregor.
Talc poudrage for malignant pleural effusion.
J Thorac Cardiovasc Surg, 51 (1966), pp. 732-738
[37.]
B.J. Leinninger, W.L. Barker, H.T. Langton.
A simplified method for management of malignant pleural effusion.
J Thorac Cardiovasc Surg, 58 (1969), pp. 758-763
[38.]
A.S. Weisberger, B. Levine, J.P. Storaasli.
Use of nitrogen mustard in treatment of serous effusions of neoplastic origin.
JAMA, 159 (1955), pp. 1704-1708
[39.]
F.J. Bonte, J.P. Storaasli, A.S. Weisberger.
Comparative evaluation of radioactive colloidal gold and nitrogen mustard in the treatment of serous effusions of neoplastic origin.
Radiology, 67 (1956), pp. 63-66
[40.]
V.B. Levison.
Nitrogen mustard in palliation of malignant effusions.
Br Med J, 1 (1961), pp. 1143-1145
[41.]
F.P. Shea.
Nitrogen mustard for control of malignant effusions.
Harper Hosp Bull, 2 (1962), pp. 239-243
[42.]
D.L. Kinsey, D. Carter, K.P. Klasenn.
Simplified management of malignant pleural effusion.
Arch Surg, 89 (1964), pp. 389-392
[43.]
G.K. Thorsud.
Pleural reactions to irritants — An experimental study with special references to pleural adhesions and concrescence in relation to pleural turnover of fluid.
Acta Chir Scand, 355 (1965), pp. 39-50
[44.]
A.W. Lees, W. Hoy.
Management of pleural effusions in breast cancer.
Chest, 75 (1979), pp. 51-53
[45.]
P. Schwandt, H. Ehrhart.
Localbehandlung von karcinomatósen Ergüssen mit Triäthylen-Thiophosphoramid (ThioTepa).
MMW, 50 (1966), pp. 2535-2539
[46.]
J. Mejer, K.M. Mortensen, H.H. Hansen.
Mepacrine hydrochloride in the treatment of malignant pleural effusion.
Scand J Resp Dis, 58 (1977), pp. 319-328
[47.]
A.P. Anderson, H. Brincker.
Intracavitary Thio-Tepa in malignant pleural and peritoneal effusions.
Acta Radiol (Ther) (Stockh), 7 (1968), pp. 369-378
[48.]
L.G. Shurland, A.S. Weisberger.
lntracavitary 5-fluoruracil in malignant effusions.
Arch lntern Med, 116 (1965), pp. 4314-4333
[49.]
T.J. Cunningham, K.B. Olson, J. Horton.
A clinical trial of intravenous and intracavitary bleomycin.
Cancer, 29 (1972), pp. 1413-1419
[50.]
T.J. Cunningham, J. Horton, K.B. Olson.
lntracavitary bleomycin in the treatment of malignant effusions.
Proc Am Soc Clic Oncol, (1972), pp. 194
[51.]
W. Paladine, T.J. Cunningham, R. Sponzo, M. Donaven, K. Olson, J. Horton.
lntracavitary bleomycin in the management of malignant effusions.
Cancer, 38 (1976), pp. 1903-1908
[52.]
M.H.N. Tattersall, R.M. Fox, E.S. Newlands, R.L. Woods.
lntracavitary doxorubicin in malignant effusions.
Lancet, i: (1979), pp. 390
[53.]
S.D. Desai, A. Figueredo.
lntracavitary doxorubicin in malignant effusions.
Lancet, 1 (1979), pp. 872
[54.]
J.S. Zelenik, A.J. Halpern, D.W. Williams.
Treatment of neoplastic effusion with clorambucyl.
Obstet Gynecol, 23 (1964), pp. 703-707
[55.]
R. Ochoa, F.J. Labrador.
Derrames pleurales en oncología.
Oncología, 3 (1978), pp. 34-35
[56.]
J.H. Müller.
Weitere Entwicklung der Therapie von Peritonealcarcinosen bei Ovarialcarcinom mit künstlicher Radioactivität (Au 198).
Gynaecologia, 129 (1950), pp. 289-298
[57.]
E.M. Kent, C. Moses.
Radioactive isotopes in the palliative management of carcinomatosis of the pleura.
J Thorac Surg, 22 (1951), pp. 503-516
[58.]
J.P. Storaasli, F.J. Bonte, D.P. King.
The use of radioactive colloidal gold in the treatment of serous effusions of neoplastic origin.
Surg Gynecol Obstet, 96 (1953), pp. 707-710
[59.]
G.A. Andrews, S.W. Root, H.D. Kerman.
lntracavitary colloidal radiogold in the treatment of effusion caused by malignant neoplasms.
Ann Surg, 137 (1953), pp. 375-381
[60.]
E.M. Kent, C. Moses, W.B. Ford.
Radioactive isotopes in the management of carcinomatosis of serous body cavities.
Arch lntern Med, 94 (1954), pp. 334-340
[61.]
M.J. Brennan, K.D. McGinnis, L. Preuss.
Experiencce with intracavitary radiogold at Henry Ford Hospital.
Henry Ford Hosp Med Bull, 4 (1956), pp. 89-93
[62.]
T. Mackay.
Radioactive colloidal gold in the treatment of pleural and peritoneal effusions of malignant origin.
Lancet, 2 (1957), pp. 761-764
[63.]
J. Dybicki, O.J. Balchum, G.R. Meneely.
Treatment of pleural and peritoneal effusion with intracavitary colloidal radiogold (Au 198).
AMA Arch Intern Med, 140 (1959), pp. 802-815
[64.]
R.G. Rose.
Intracavitary radioactlve colloidal gold: results in 257 cancer patients.
J Nucl Med, 3 (1962), pp. 323-331
[65.]
T.W. Botsford.
Experiences with radioactive colloidal gold in the treatment of pleural effusion caused by metastatic cancer of the breast.
N Engl J Med, 270 (1964), pp. 552-555
[66.]
K.H. Möhlen, F.K. Beller.
Use of radioactive gold in the treatment of pleural effusions caused by metastatic cancer.
J Cancer Res Clin Oncol, 94 (1979), pp. 81-85
[67.]
M.L. Jacobs.
Use of radioactive chromic phosphate in pleural effusion.
Cali f Med, 81 (1954), pp. 268-271
[68.]
R.H. Lange, J.L. Shields, H.M. Rozendaal.
Colloidal radioactive chromic phosphate in the control of malignant effusions.
NY State J Med, 56 (1956), pp. 1928-1931
[69.]
M.L. Jacobs.
Radioactive colloidal chromic phosphate to control pleural effusion and ascites.
JAMA, 166 (1958), pp. 597-599
[70.]
C.H. Chang, A.H. Janzen, A.B. Skorneck.
Treatment of malignant effusions by intracavitary injection of radioactive colloidal gold.
Am J Roentgenol, 77 (1957), pp. 486-492
[71.]
I.M. Ariel, R. Oropeza, G.T. Pack.
Intracavitary administration of radioactive isotopes in the control of effusions due to cancer.
Cancer, 19 (1966), pp. 1096-1102
[72.]
R.Y. Card, D.R. Cole, U.K. Henschke.
Summary of ten years of the use of radioactive colloids in intracavitary therapy.
J Nucl Med, 1 (1960),
[73.]
R.M. O’Bryant, R.W. Talley, N.J. Brennan.
Critical analysis of the control of malignant effusions with radioisotopes.
Henry Ford Hosp Med J, 16 (1968), pp. 3-14
[74.]
A. El-Mahdi, A. Levene, S. Lott.
Observations and management of malignant pleural effusions in breast carcinoma.
John's Hopkins Med J, 132 (1973), pp. 44-49
[75.]
D.B. Rochlin, C.R. Smart, D.E. Wagner, R.M. Silva.
The control of recurrent malignant effusions using quinacrine hydrochloride.
Surg Gynecol Obstet, 118 (1964), pp. 991-994
[76.]
J.E. Ultman, A. Gelhorn, M. Osnos.
The effect of quinacrine on neoplastic effusions and certain of their enzymes.
Cancer, 16 (1963), pp. 283-288
[77.]
M.R. Dollinger, I.H. Krakoff, D.A. Karnofsky.
Quinacrine (Atabrine) in the treatment of neoplastic effusions.
Ann Intern Med, 66 (1967), pp. 249-257
[78.]
J.A. Hickman, M.C. Jones.
Treatment of neoplastic pleural effusions with local ¡nstillation of quinacrine (Mepacrine) hydrochloride.
Thorax, 25 (1970), pp. 226-229
[79.]
B. Avartson, J. Boe, J. Stiksa, B.G. Simonsson.
Mepacrine in malignant pleural effusions.
Scand J Respir Dis, 54 (1973), pp. 132-135
[80.]
E.R. Borja, R.P. Pugh.
Single-dose quinacrine (Atabrine) an thoracostomy in the control of pleural effusion in patients with neoplastic disease.
Cancer, 31 (1973), pp. 899-902
[81.]
L.P. Johnson, S.E. Riokin, E.L. Weber.
Palliation in malignant pleural effusion.
Am Surg, 41 (1975), pp. 529-534
[82.]
J. Stiksa, R. Korsagaard, B.G. Simonsson.
Treatment of recurrent pleural effusion by pleurodesis with quinacrine.
Scand J Respir Dis, 60 (1979), pp. 197-205
[83.]
G.L. Engel, J. Romano, E.B. Ferris.
Effect of quinacrine (Atabrine) on the central nervous system.
Arch Neurol Psychiat, 58 (1947), pp. 337-350
[85.]
I. Borda, M. Krant.
Convulsions following intrapleural administration of quinacrine hydrochloride.
JAMA, 201 (1967), pp. 173-174
[86.]
Council on Drugs.
An agent for the palliative treatment of neoplastic effusions, quinacrine (Atabrine) hydrochloride.
JAMA, 195 (1966), pp. 161
[87.]
J. Boe, E. Florvaag.
Quimical pleurodesis induced by mepacrine hydrochloride.
Tids Norsk Laegefor, 23 (1976), pp. 1203-1206
[88.]
S.A. Taylor, N.S. Hooton, A.M. McArthur.
Quinacrine in the management of malignant pleural effusions.
Br J Surg, 64 (1977), pp. 52-53
[89.]
T.C. Bayly, O.L. Kisner, A. Sybert.
Tetracydine and quinacrine in control of malignant pleural effusions.
Cancer, 41 (1978), pp. 1188-1192
[90.]
J.S. Chambers.
Palliative treatment of neoplastic pleura] effusion with intercostal intubation and tale instillation.
West J Surg Obstet Gynecol, 66 (1958), pp. 26-28
[91.]
E.W. Grabowski, R.A. Malt.
Tales for pleural poudrage. Physical and Chemical factors in therapeutic effect.
J Thorac Cardiovasc Surg, 56 (1968), pp. 760-764
[92.]
S.J. Johnstone.
Minerals for Chemical and allied industries..
John Wikley and Sons, Inc., (1954), pp. 493
[93.]
B. Weiss, E.A. Boettner.
Commercial talc and talcosis.
S. Arch Environ Health, 14 (1967), pp. 304-308
[94.]
G.J. Haupt, R.C. Camishion, J.Y. Templeton.
Treatment of maligmant pleural effusion by talc poudrage.
JAMA, 172 (1960), pp. 918-921
[95.]
R.C. Camishion, J.H. Gibbson, T.F. Nealon.
Talc poudrage in the treatment of pleural effusion due to cancer.
Surg Clin North Am, 42 (1962), pp. 1521-1526
[96.]
A.R. Shedbalkar, J.M. Head, L.R. Head, D.J. Murphy, J.H. Mason.
Evaluation of talc pleural synphysis in the management of malignant pleural effusions.
J Thorac Cardiovasc Surg, 61 (1971), pp. 492-497
[97.]
G. Pizzocaro, G.L. Ravasi, F. Bozzetti, M. Vagliani, G. La Monica.
L’instaleamento del cavo pleurico nel trattamento dei versamenti neoplastiei recidivante.
Tumori, 59 (1973), pp. 287-293
[98.]
J. Teijeira, I. Sánchez, J.M. Rodríguez, C.M. Gómez Durán.
Sínfisis pleural química como tratamiento de los derrames pleurales malignos recidivantes.
Cirugía Española, 24 (1974), pp. 81-84
[99.]
H.R.S. Harley.
Malignant pleural effusions and their treatment by intercostal talc pleurodesis.
Br J Disc Chest, 73 (1979), pp. 173-177
[100.]
G.R. Jones.
Treatment of recurrent malignant pleural effusion by iodised talc pleurodesis.
Thorax, 24 (1969), pp. 69-73
[101.]
R.H. Adler, B.W. Rappole.
Malignant pleural effusion and talc powder aerosol treatment.
Surgery, 62 (1967), pp. 1000-1006
[102.]
R.H. Adler, I. Sayek.
Treatment of malignant pleural effusion: A method using tube thoracostomy and talc.
Ann Thorac Surg, 22 (1976), pp. 8-15
[103.]
J. Scarbonchi.
Tratamiento paliativo de los derrames pleurales neoplásicos. Talcage de la pleura bajo pleuroscopia con mezcla de talco y virgimycina.
Mars Med, 104 (1967), pp. 939-947
[104.]
G. Roche, Y. Delanoe, N. Moayer.
Talcage de la plevre sous pleuroscopie resultats indications technique.
J Fr Med Chir Thorac, 1 (1963), pp. 677-692
[105.]
C. Boutin, P. Cargnino, J. Viallat.
La thoracoscopie: interet actuel.
Sa place dans le diagnostic des pleuresies chroniques. Poumon, 35 (1979), pp. 23-29
[106.]
D. Weissberg, M. Kaufman, Z. Zurkowski.
Pleuroscopy in patients with pleural effusion and pleural masses.
Ann Throac Surg, 29 (1980), pp. 205-208
[107.]
J. Scarbonchi, G. Boutin, P. Cargnino, T. ScarbonchiEfimieff.
Le talcage pleural dans les pleuresies cancereuses.
Poumon, 37 (1981), pp. 283-289
[108.]
D. Weissberg.
Talc pleurodesis. A controversial issue.
Poumon, 37 (1981), pp. 291-294
[109.]
S.A. Sahn, D.E. Potts.
The effect of tetracydine on rabbit pleura.
Am Rev Respir Dis, 117 (1978), pp. 493-499
[110.]
S.A. Sahn, J.T. Good, D.E. Potts.
The pH of sclerosing agents. A determinant of pleural synphysis.
Chest, 76 (1979), pp. 198-200
[111.]
H.W. Wallach.
Intrapleural tetracydine for malignant pleural effusions.
Chest, 68 (1975), pp. 510-512
[112.]
J. Moya, M. Mateu, L. Ballús, M. Giménez, A. Roig, E. Letang, J. Sánchez-Lloret.
La instilación intrapleural de tetraciclinas como tratamiento del síndrome de ocupación pleural.
Arch Bronconeumol, 15 (1979), pp. 60-63
[113.]
J.T. Good, S.A. Sahn.
Intrapleural therapy with tetracycline in malignant pleural effusions. The importance of proper technique.
Chest, 74 (1978), pp. 602
[115.]
H.E. Webb, S.W. Caten, C.P. Pike.
Treatment of malignant ascitic and pleural effusions with Corynebaclerium parvum.
Brit Med Jour, 1 (1978), pp. 338-340
[116.]
L. Israel, B. Halpern.
Le Corynebaclerium parvum daos les cancers avances.
Nouv Press Med, 1 (1972), pp. 19-23
[117.]
P. Serrou, D. Coupissol, L. Israël.
Epanchements pleuraux: traitement local par CBP.
Nouv Press Med, 25 (1980), pp. 1777-1778
[118.]
J.W. Millar, A.M. Hunter, N.W. Horne.
Intrapleural inmunotherapy with CBP in recurrent malignant pleural effusions.
Thorax, 35 (1980), pp. 856-858
[119.]
I.W.B. Grant.
Intrapleural inmunotherapy with CBP in recurrent malignant pleural effusions.
Thorax, 36 (1981), pp. 319-320
[120.]
R. Schindl, K. Mayer.
Lokale Enzymtherapie maligner Pleuraergüsse.
Wien Klin Woch, 85 (1973), pp. 853-854
[122.]
I. Kalnins, T.A. Torda, J.S. Wright.
Bilateral simultaneous pleurodesis by median sternotomy for spontaneous pneumothorax.
Ann Thorax Surg, 15 (1973), pp. 202-203
[123.]
D. Weeden, G.H. Smith.
Surgical experience in the management of spontaneous pneumothorax 1972-82.
Thorax, 38 (1983), pp. 737-743
[124.]
R.C. Goldszer, J. Bennett, J. van Campen, J. Rudmitzky.
Intrapleural tetracycline for spontaneous pneumothorax.
JAMA, 241 (1979), pp. 724-725
[125.]
U. Wied, E. Halkier, K. Hoeier-Madsen, B. Plucnar, E. Rasmussen, J. Sparup.
Tetracycline versus silver nitrate pleurodesis in spontaneous pneumothorax.
J Thorac Cardiovasc Surg, 86 (1983), pp. 591-593
[126.]
A. Satller.
Pleural biopsy: results obtained and their practical significance.
Symposium Ciba, 9 (1961), pp. 109-121
[127.]
A. Joynt.
Treatment of spontaneous pneumothorax with caolin.
Dis Chest, 34 (1958), pp. 514-520
[128.]
L. Sengupta.
Treatment of recurrent spontaneous pneumothorax with yodiced talcage.
Brit J Dis Chest, 57 (1963), pp. 197-199
[129.]
P. Nandi.
Recurrent spontaneous pneumothorax: an effective method of talc poudrage.
Chest, 77 (1980), pp. 493-495
[130.]
J.H. Knowles, R. Gorlin, C.E. Storey.
Effects of pleural talc poudrage on pulmonary function.
J Thoracic Surg, 34 (1957), pp. 250-256
[131.]
J.E. Rinaldo, G.R. Owens, R.M. Rogers.
Adult respiratory distress syndrome following intrapleural instillation of talc.
.J Thorac Cardiovasc Surg, 85 (1983), pp. 523-526
[132.]
D. Weissberg.
Talc and adult respiratory distress syndrome.
J Thorac Cardiovasc Surg, 87 (1984), pp. 474-475
[133.]
A.J. Larrieu, G.F.O. Tyers, E.H. Williams, M.J. O’Neill, J.R. Derrick.
Intrapleural instillation of quinacrine for treatment of recurrent spontaneous pneumothorax.
Ann Thorax Surg, 28 (1979), pp. 146-150
[134.]
J. Andersen, H. Nissen.
Results of silver nitrate pleurodesis in spontaneous pneumothorax.
Chest, 54 (1968), pp. 230-233
[135.]
V. Wied, K. Andersen, A. Schultz, E. Rasmussen, S. WattBoolsen.
Silver nitrate pleurodesis in spontaneous pneumothorax.
Scand J Thorac Cardiovasc Surg, 15 (1981), pp. 305-307
[136.]
T.C. Laipply, J.C. Sherrick.
Intrathoracic angiomyomatous hiperplasia associated with chronic chylothorax.
Lab Invest, 7 (1958), pp. 387-400
[137.]
D. Rainhoff.
Linfangiomatous malformation of thoracic duct associated with chilous pleural effusion.
Ann Surg, 159 (1964), pp. 180-184
[138.]
R.H. Adler, L. Levinsky.
Persistent chylothorax.
Treatment by talc pleurodesis. J Thorac Cardiovasc Surg, 76 (1978), pp. 859-864
[139.]
J. Lieberman, C.M. Agliozzo.
Intrapleural nitrogen mustard for treating chylous effusion of pulmonary lynphangioleiomyomatosis.
Cancer, 33 (1974), pp. 1151-1505
[140.]
J. Rubíes, R. Bacardí, M. Soler.
Hidrotórax en la cirrosis hepática.
Med Clin (Barcelona), 57 (1971), pp. 85-92
[141.]
K.R. Falchuk, I. Jacoby, W.S. Colucci, M.E. Rybak.
Tetracycline pleural synfisis for recurrent hydrothorax complicating cirrhosis. A new approach to treatment.
Gastroenterology, 72 (1977), pp. 319-321
Copyright © 1984. Sociedad Española de Neumología y Cirugía Torácica
